In the study of congenital hyperinsulinism now enrolling phase III sunRIZE trial

sunrize logo

Rezolute profiled in Nature’s BioPharma Dealmakers, Nature Biotechnology, and Nature Reviews Drug Discovery, November 2019 editions

Back to Careers